Anesthesia management for percutaneous mitral valve repair in a patient with mitochondrial cardiomyopathy and low cardiac function: a case report

Russell OM, Gorman GS, Lightowlers RN, Turnbull DM. Mitochondrial diseases: hope for the future. Cell. 2020;181:168–88.

Article  CAS  PubMed  Google Scholar 

Braunwald E. Mitochondrial cardiomyopathy: a fertile field for research. Eur Heart J. 2023;44:2361–2.

Article  PubMed  Google Scholar 

Morgan PG, Hoppel CL, Sedensky MM. Mitochondrial defects and anesthetic sensitivity. Anesthesiology. 2002;96:1268–70.

Article  PubMed  Google Scholar 

Wolf A, Weir P, Stone J, Shield J. Impaired fatty acid oxidation in propofol infusion syndrome. Lancet. 2001;357:606–7.

Article  CAS  PubMed  Google Scholar 

Niezgoda J, Morgan PG. Anesthetic considerations in patients with mitochondrial defect. Paediatr Anaesth. 2013;23:785–93.

Article  PubMed  PubMed Central  Google Scholar 

Kitaura A, Kosumi R, Iwamoto T, Nakao S. Remimazolam anesthesia for transcatheter mitral valve repair in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome: a case report. JA Clin Rep. 2022;8:38.

Article  PubMed  PubMed Central  Google Scholar 

Huruma T, Saji M, Nanasat M, Isobe M. Successful transcatheter mitral valve repair for functional mitral regurgitation in a patient with mitochondrial cardiomyopathy: a case report. Eur Heart J. 2023;7:ytad440.

Article  Google Scholar 

Drissen J, Willems S, Dercksen S, Giele J, van der Staak F, Smeitink J. Anesthesia-related morbidity and mortality after surgery for muscle biopsy in children with mitochondrial defects. Paediatr Anaesth. 2007;17:16–21.

Article  Google Scholar 

Hanley PJ, Ray J, Brandt U, Daut J. Halothane, isoflurane and sevoflurane inhibit NADH:ubiquinone oxidoreductase (complex I) of cardiac mitochondria. J Physiol. 2002;544:687–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hirata N, Shim YH, Pravdic D, Lohr NL, Pratt PF Jr, Weihrauch D, et al. Isoflurane differentially modulates mitochondrial reactive oxygen species production via forward versus reverse electron transport flow: implications for preconditioning. Anesthesiology. 2011;115:531–40.

Article  CAS  PubMed  Google Scholar 

Bergamini C, Moruzzi N, Volta F, Faccioli L, Gerdes J, Mondardini MC, Fato R. Role of mitochondrial complex I and protective effect of CoQ10 supplementation in propofol induced cytotoxicity. J Bioenerg Biomembr. 2016;48:413–23.

Article  CAS  PubMed  Google Scholar 

Wu GJ, Tai YT, Chen TL, Lin LL, Ueng YF, Chen RM. Propofol specifically inhibits mitochondrial membrane potential but not complex I NADH dehydrogenase activity, thus reducing cellular ATP biosynthesis and migration of macrophages. Ann N Y Acad Sci. 2005;1042:168–76.

Article  CAS  PubMed  Google Scholar 

Hemphill S, McMenamin L, Bellamy MC, Hopkins PM. Propofol infusion syndrome: a structured literature review and analysis of published case reports. Br J Anaesth. 2019;122:448–59.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Uezono S, Hotta Y, Takakuwa Y, Ozaki M. Acquired carnitine deficiency: a clinical model for propofol infusion syndrome? Anesthesiology. 2005;103:909.

Article  PubMed  Google Scholar 

Savard M, Dupre N, Turgeon AF, Desbiens R, Langevin S, Brunet D. Propofol-related infusion syndrome heralding a mitochondrial disease: case report. Neurology. 2013;81:770–1.

Article  PubMed  PubMed Central  Google Scholar 

Vanlander AV, Jorens PG, Smet J, De Paepe B, Verbrugghe W, Van den Eynden GG, et al. Inborn oxidative phosphorylation defect as risk factor for propofol infusion syndrome. Acta Anaesthesiol Scand. 2012;56:520–5.

Article  CAS  PubMed  Google Scholar 

Colleoni M, Costa B, Gori E, Santagostino A. Biochemical characterization of the effects of the benzodiazepine, midazolam, on mitochondrial electron transfer. Pharmacol Toxicol. 1996;78:69–76.

Article  CAS  PubMed  Google Scholar 

Doi M, Morita K, Takeda J, Sakamoto A, Yamakage M, Suzuki T. Efficacy and safety of remimazolam versus propofol for general anesthesia: multicenter, single-blind, randomized, parallel-group, phase IIb/III trial. J Anesth. 2020;34:543–53.

Article  PubMed  Google Scholar 

Doi M, Hirata N, Suzuki T, Morisaki H, Morimatsu H, Sakamoto A. Safety and efficacy of remimazolam in induction and maintenance of general anesthesia in high-risk surgical patients (ASA Class III): results of a multicenter, randomized, double-blind, parallel-group comparative trial. J Anesth. 2020;34:491–501.

Article  PubMed  Google Scholar 

Yoshikawa Y, Oura S, Kanda M, Chaki T, Hirata N, Edanaga M, et al. Comparison of the negative effect of remimazolam and propofol on cardiac contractility: Analysis of a randomized parallel-group trial and a preclinical ex vivo study. Clin Exp Pharmacol Physiol. 2024;51:e13840.

Article  CAS  PubMed  Google Scholar 

Nam SW, Yim S, Choi CI, Park I, Joung KW, Song IA. Effects of remimazolam on hemodynamic changes during cardiac ablation for atrial fibrillation under general anesthesia: a propensity-score-matched retrospective cohort study. Can J Anaesth. 2023;70:1495–503.

Article  CAS  PubMed  Google Scholar 

Hasegawa G, Hirata N, Yoshikawa Y, Yamakage M. Differential effects of remimazolam and propofol on heart rate variability during anesthesia induction. J Anesth. 2022;36:239–45.

Article  PubMed  Google Scholar 

Hirata N. Remimazolam for cardiovascular anesthesia. J Anesth. 2023;37:825–7.

Article  PubMed  Google Scholar 

Satoh T, Nishihara N, Sawashita Y, Ohno S, Hirata N, Yamakage M. Remimazolam anesthesia for mitraclip implantation in a patient with advanced heart failure. Case Rep Anesthesiol. 2021;2021:5536442.

PubMed  PubMed Central  Google Scholar 

Fujii E, Tanaka-Mizuno S, Fujino K, Fujii M, Furuno M, Sugimoto Y, et al. Dexmedetomidine attenuates the positive chronotropic effects of intravenous atropine in patients with bradycardia during spinal anesthesia: a retrospective study. JA Clin Rep. 2018;4:70.

Article  PubMed  PubMed Central  Google Scholar 

Sajima T, Onimaru T, Sawamura S. Temporary worsening of mitral regurgitation due to conduction disturbance after transcatheter aortic valve implantation. JA Clin Rep. 2021;7:87.

Article  PubMed  PubMed Central  Google Scholar 

留言 (0)

沒有登入
gif